The test uses RNA contained in blood to measure the level of the expression of seven genes and provide an assessment of a patient’s risk of having colorectal cancer.
The test, which requires a small sample of blood, was originally developed by GeneNews.
Related Articles on Colorectal Cancer Prevention:
Ohio Gastroenterology Group Provides Free Colonoscopies to Uninsured
American College of Physicians Issues New Guidance for Colorectal Cancer Screening
Kentucky’s Tri-State Gastroenterology Associates to Provide Free Colon Cancer Education Program
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.